Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

NIH Forms Precision Medicine Panel

by Andrea Widener
April 6, 2015 | A version of this story appeared in Volume 93, Issue 14

The National Institutes of Health has appointed an expert panel to detail the way forward for the White House’s Precision Medicine Initiative. The research plan, first proposed by President Barack Obama in his State of the Union speech earlier this year, would look at the role that differences among individuals play in health to help doctors devise individualized treatment and prevention strategies. Obama called for $215 million for the initiative in his 2016 budget proposal. More than half of this funding would go toward recruiting 1 million-plus participants to donate tissue samples and provide biological, lifestyle, environmental, and behavioral information for research. The panel will lay out a vision and goals for this immense project. Chairs of the panel are Richard Lifton, a geneticist at Yale University; Bray Patrick-Lake, a clinical trial expert at Duke University; and Kathy Hudson, deputy director of science, outreach, and policy at NIH.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.